Literature DB >> 10536683

Opioid peptides and the heart.

B A Barron.   

Abstract

The heart is a complex neuroendocrine (opioids, NPY, VIP) or mechanoendocrine (ANP) organ. Opioid peptides and receptors are present in the heart and nerves such that they can easily modulate cardiac function. Cardiac opioids may have autocrine, paracrine and endocrine function. The challenge is to find the signal that turns them on and then what they do in the face of an overwhelmingly redundant system making knock-out technology hard to interpret. Determining the cardiac release of opioids in an intact system still requires a larger animal model.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10536683     DOI: 10.1016/s0008-6363(99)00112-1

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  8 in total

Review 1.  Reperfusion injury: does it exist?

Authors:  Garrett J Gross; John A Auchampach
Journal:  J Mol Cell Cardiol       Date:  2006-10-27       Impact factor: 5.000

2.  Negative inotropic effects of tumour necrosis factor-alpha and interleukin-1beta are ameliorated by alfentanil in rat ventricular myocytes.

Authors:  D J Duncan; P M Hopkins; S M Harrison
Journal:  Br J Pharmacol       Date:  2007-02-05       Impact factor: 8.739

3.  Evidence for MOR on cell membrane, sarcoplasmatic reticulum and mitochondria in left ventricular myocardium in rats.

Authors:  Sascha Treskatsch; Mohammed Shaqura; Lukas Dehe; Torsten K Roepke; Mehdi Shakibaei; Michael Schäfer; Shaaban A Mousa
Journal:  Heart Vessels       Date:  2015-12-19       Impact factor: 2.037

4.  The Pharmacogenetic Footprint of ACE Inhibition: A Population-Based Metabolomics Study.

Authors:  Elisabeth Altmaier; Cristina Menni; Margit Heier; Christa Meisinger; Barbara Thorand; Jan Quell; Michael Kobl; Werner Römisch-Margl; Ana M Valdes; Massimo Mangino; Melanie Waldenberger; Konstantin Strauch; Thomas Illig; Jerzy Adamski; Tim Spector; Christian Gieger; Karsten Suhre; Gabi Kastenmüller
Journal:  PLoS One       Date:  2016-04-27       Impact factor: 3.240

5.  Diuretic Activity of a Novel Peripherally-Restricted Orally-Active Kappa Opioid Receptor Agonist.

Authors:  Tyler C Beck; Matthew A Hapstack; Gautam S Ghatnekar; Thomas A Dix
Journal:  Med Sci (Basel)       Date:  2019-08-31

6.  Serum Proenkephalin A Levels and Mortality After Long-Term Follow-Up in Patients with Type 2 Diabetes Mellitus (ZODIAC-32).

Authors:  Kornelis J J van Hateren; Gijs W D Landman; Jarinke F H Arnold; Hanneke Joosten; Klaas H Groenier; Gerjan J Navis; Andrea Sparwasser; Stephan J L Bakker; Henk J G Bilo; Nanne Kleefstra
Journal:  PLoS One       Date:  2015-07-28       Impact factor: 3.240

7.  Proenkephalin A Adds No Incremental Prognostic Value After Acute Ischemic Stroke.

Authors:  Philipp Gruber; Felix Fluri; Juliane Schweizer; Andreas Luft; Beat Müller; Mirjam Christ-Crain; Mira Katan
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

Review 8.  Opioids in cancer: The κ‑opioid receptor (Review).

Authors:  Qier Zhou; Zhiwei Zhang; Songkai Long; Wanjun Li; Baiyun Wang; Na Liang
Journal:  Mol Med Rep       Date:  2021-12-08       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.